Antitetanus Vaccination for People Older Than 65 Years. (VAT65)

Antitetanus Vaccination for People Older Than 65 Years in the Auvergne-Rhône-Alpes (France) Region Depending on the Demographic and Medical Practice of Their Medical Practitioner.

In the last ten years, more than one hundred generalized tetanus cases were declared in France. Most of them were affecting people older than 70 years with an important mortality (around 28%). It is know that the only way to protect ourselves from this disease is the vaccination. In France tetanus vaccination is mandatory since 1940.

Nowaday none study looked specifically for the vaccination of people older than 65 years. The hypothesis is: there is a difference in the tetanus vaccination coverage for people older than 65 years depending on the demographic and medical practice of their general practitioner.

Study Overview

• Status: Completed
• Conditions: Tetanus
• Intervention / Treatment: Other: Questionnaire Patients; Other: Questionnaire General practitioner

• Study Type: Observational
• Enrollment (Actual): 261

Contacts and Locations

Study Locations

• France
  • Bron, France, 69677
    • Service Urgence et Réanimation Pédiatrique Hôpital Femme Mère Enfant Groupement Hospitalier Est

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The population will be all patients older than 65 years who are consulting their general practitioner and accepting to participate to the study. And their general practitioner.

Description

Inclusion Criteria:

• Patients older than 65 years consulting their attending physician in and who agreed to participate in the study.
• The doctors included are general practitioners located in a liberal office in the "Auvergne Rhône Alpes" region for which the URPS ("Union régional des Professionnels de Santé") has an email address.

Exclusion Criteria:

• None

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patients; People older than 65 years in the Auvergne-Rhônes-Alpes region who are consulting their general practitioner.	Other: Questionnaire Patients; Patient will have to answer a quiz which is about their vaccination against tetanus.
General practitioner; General practitioner of the Auvergne-Rhônes-Alpes region	Other: Questionnaire General practitioner; General practitioner will have to answer a quiz which is about their medical practice concerning vaccination against tetanus.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Tetanus vaccination coverage	Patient will have to answer a quiz which is about their vaccination against tetanus.	About 5 minutes

Collaborators and Investigators

• Sponsor: Hospices Civils de Lyon

Study record dates

Study Major Dates

• Study Start (Actual): November 9, 2017
• Primary Completion (Actual): December 23, 2017
• Study Completion (Actual): December 23, 2017

Study Registration Dates

• First Submitted: August 28, 2017
• First Submitted That Met QC Criteria: August 28, 2017
• First Posted (Actual): August 30, 2017

Study Record Updates

• Last Update Posted (Actual): June 12, 2018
• Last Update Submitted That Met QC Criteria: June 8, 2018
• Last Verified: August 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Infections; Bacterial Infections; Bacterial Infections and Mycoses; Gram-Positive Bacterial Infections; Clostridium Infections; Tetanus
• Other Study ID Numbers: 69HCL17_0375

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No